Physician
Cardiology
Dr. Nanette K. Wenger, MD
|
|
Give Review
Nanette Wenger is an expert in the field of Cardiology. He went to medical school at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He received 1 awards: "Whos Who in Medicine and Healthcare". Nanette Wenger is a published physician. He published 99 publications, including: 'Women and heart disease, the underrecognized burden: sex differences, biases, and unmet clinical and research challenges.' He accepts all Medicare patients.
Publications
- Women and Heart disease, the underrecognized burden: sex differences, biases, and unmet clinical and research challenges.
- Microvascular Angina: an update on diagnosis and treatment.
- Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.
- Cardiac rehabilitation and risk reduction: time to "rebrand and reinvigorate".
- Prevention of Cardiovascular Disease: Highlights for the Clinician of the 2013 American College of Cardiology/American Heart Association Guidelines.
- Are we there yet? Closing the gender gap in coronary Heart disease recognition, management and outcomes.
- Recognizing Pregnancy-Associated Cardiovascular Risk Factors.
- Cardiovascular care for women: the 10-Q Report and beyond.
- Is There a Role for Menopausal Hormone Therapy (MHT) for Cardiovascular Disease Prevention in Select Postmenopausal Women?
- What do the recent American Heart Association/American College of Cardiology Foundation Clinical Practice Guidelines tell us about the evolving management of coronary ...
- Physical activity and structured exercise for patients with stable ischemic Heart disease.
- Cardiac rehabilitation and cardiovascular disability: role in assessment and improving functional capacity: a position statement from the American Association of Cardi...
- What's New in Antiplatelet and Anticoagulant Therapy Recommendations for Unstable Angina/Non-ST-Elevation Myocardial Infarction: 2012 Focused Update From the American ...
- Hormone therapy not recommended for chronic Disease prevention in menopausal women.
- Strategies and Methods to Study Sex Differences in Cardiovascular Structure and Function: A Guide for Basic Scientists.
- Management of Hypertension in women.
- Sex/gender differences in cardiovascular Disease prevention: what a difference a decade makes.
- Coronary Heart disease in men and women: does 1 size fit all? No!
- What do the 2011 american Heart association guidelines tell us about prevention of cardiovascular disease in women?
- Women and Heart Disease: Knowledge, Worry, and Motivation.
- Cardiovascular Disease in the Elderly.
- Gender Differences in Cardiovascular Risk: A Varying Variable.
- Science and the practice of cardiovascular medicine in the geriatric population.
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction A...
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: ...
- 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline...
- 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)...
- Cardiac care for older adults. Time for a new paradigm.
- Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american Heart association.
- Women's Heart health: a worldwide challenge.
- Treatment of Heart failure in African Americans--a call to action.
- Electrocardiograms of menopausal women with coronary Heart disease or at increased risk for its occurrence.
- Angina in women.
- Toward optimal health: advances in the cardiovascular care of women. [An interview with Jodi R. Godfrey and Wenger K. Nanette].
- Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly Z...
- The female Heart is vulnerable to cardiovascular disease: emerging prevention evidence for women must inform emerging prevention strategies for women.
- Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study.
- Menopausal hormone therapy for cardiovascular protection--unfulfilled expectations.
- Race, gender, and mortality in adults > or =65 years of age with incident Heart failure (from the Cardiovascular Health Study).
- Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and...
- Correlates of sexual satisfaction among sexually active postmenopausal women in the Women''s Health Initiative-Observational Study.
- Intensive lipid-lowering with atorvastatin for secondary prevention in patients after Coronary artery bypass surgery.
- A statement on ethics from the Heart Group.
- Current status of cardiac rehabilitation.
- Sexual satisfaction and cardiovascular Disease: the Women's Health Initiative.
- Women in leadership positions in the medical academic enterprise: what are the next steps?
- The geriatric paradox.
- Preventing cardiovascular Disease in women: an update.
- Women, their age, and their cholesterol values.
- Progress in treating Hypertension.
- Accountability and transparency in medical publishing: position and policies of le jacq on authorship, acknowledgments, conflicts of interest, and secondary and redund...
- Newer diagnostic strategies, application of evidence-based therapies: improving cardiovascular outcomes in an expanding elderly population.
- Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardio...
- Exploring sex/gender differences in women's cardiovascular health.
- Drug choice affects treatment compliance and blood pressure outcomes in elderly Hypertensive patients.
- Heightened cardiovascular risk in diabetic women: can the tide be turned?
- Patient selection, statistical presumption, and uncertainty of outcomes.
- Cardiovascular risk factors, cardiovascular Disease, cardiovascular drug therapies, and dementia/cognitive dysfunction: how do the pieces of the puzzle fit together?
- Observational studies can help fill important gaps in understanding and treating cardiovascular Disease in the elderly.
- Effect of high-dose atorvastatin on hospitalizations for Heart failure: subgroup analysis of the Treating to New Targets (TNT) study.
- Gender comparison of efficacy and safety of ranolazine for chronic Angina pectoris in four randomized clinical trials.
- Denial of standard treatment to the elderly: why?
- Who should be treated with implantable cardioverter-defibrillators?
- Lipid abnormalities in women: data for risk, data for management.
- Enrollment and maintenance of elderly patients in cardiovascular clinical trials.
- Time course of depression and outcome of Myocardial infarction.
- Valvular Heart disease at elderly age: new vistas.
- Gender differences in short-term cardiovascular outcomes after percutaneous Coronary interventions.
- Coronary risk attributes, Coronary risk reduction, and clinical outcomes.
- Baseline characteristics of menopausal women with coronary Heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
- Medicare drug therapy in the elderly: pharmacotherapy, politics, and economics at the crossroads.
- A focus on Heart failure and other age-related cardiovascular conditions.
- Secondary prevention of coronary Heart disease in elderly patients.
- Menopausal hormone therapy: currently no evidence for cardiac protection.
- Evidence-based management of Coronary artery disease in the elderly--current perspectives.
- Approaching cardiac Arrhythmias in the elderly patient.
- Chronic kidney Disease and cognitive impairment in menopausal women.
- Recognition and prevention of cardiovascular Disease in women.
- Modern cardiac electrophysiology and the elderly.
- Management strategies of dyslipidemia in the elderly: 2005.
- Evidence-based management of Acute myocardial infarction in the elderly--current perspectives.
- Hippocrates, Maimonides, and End-of-Life Issues.
- Common cardiac conditions in the elderly are still not well understood.
- Diet and exercise for perimenopausal women lifestyle interventions can decrease cardiovascular risk.
- Chronic kidney Disease is a cardiovascular problem--implications for lipid management.
- The elderly and cardiovascular Disease: some differences, but many similarities to their younger counterparts.
- Dyslipidemia as a risk factor at elderly age.
- The Cardiovascular Health Study: a national treasure of cardiovascular information about the elderly.
- Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen/progestin combinations, and nonusers.
- You've come a long way, baby: cardiovascular health and Disease in women: problems and prospects.
- Coronary Heart disease: the female Heart is vulnerable.
- Is what's good for the gander good for the goose?
- HT and CVD prevention. from myth to reality.
- New frontiers in cardiovascular aging.
- Drug therapy in the elderly.
- Nanette Kass Wenger, MD: a conversation with the editor [interviewed by William Clifford Roberts].
- Anticoagulation at elderly age: the challenge to do better.
- Review of the International Position Paper on Women's Health and Menopause: a comprehensive approach.
Schools
Harvard Medical School
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Health Alliance
- Medicare Advantage PFFS
- Choice Care PPO
- Preferred PPO
- Medicaid
- Medicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- Whos Who in Medicine and Healthcare
Education
-
Mount Sinai School of Medicine -
Harvard Medical School
Hospital
-
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1033214622 | |
| NPPES Provider LastName | WENGER | |
| NPPES Provider FirstName | NANETTE | |
| NPPES Provider ZIPCode | 303033049 | |
| NPPES Provider State | GA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1366.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1033214622 |
| Last Name Of The Provider | WENGER |
| First Name Of The Provider | NANETTE |
| View All |
Similar Doctors
|
|
Dr. Michael S. Lloyd, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sandeep K. Goyal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meenakshi A. Bhalla, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sally G. Beer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendy M. Book, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew L. Smith, MD |
|
|
Dr. Gregory B. Ang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mahmoud H. Abdou, MD |
|
|
Dr. Paolo Raggi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer R. Brown, MD |
|
|
Mary E. Long, PA-C |